Seborrhoeic dermatitis.

Ijaz, N; Fitzgerald, D

Ijaz, N; Fitzgerald, D.

Affiliation

Ijaz N; Specialty Doctor in Dermatology, Dermatology Department, Salford Royal Hospital, Manchester M6 8HD.
Fitzgerald D; Consultant, Dermatology Department, Salford Royal Hospital, Manchester.

Br J Hosp Med (Lond) ; 78(6): C88-C91, 2017 Jun 02.

Article in En | MEDLINE | ID: mdl-28614013

Subject(s)

Adrenal Cortex Hormones/therapeutic use; Antifungal Agents/therapeutic use; Dermatitis, Seborrheic/therapy; Enzyme Inhibitors/therapeutic use; Keratolytic Agents/therapeutic use; Phototherapy; Administration, Cutaneous; Brain Injuries, Traumatic/epidemiology; Calcineurin Inhibitors; Dermatitis, Seborrheic/epidemiology; Dermatitis, Seborrheic/immunology; Dermatomycoses/epidemiology; Diet; Facial Dermatoses; Humans; Imidazoles/therapeutic use; Malassezia; Organometallic Compounds/therapeutic use; Parkinson Disease/epidemiology; Pyridines/therapeutic use; Risk Factors; Scalp Dermatoses; Selenium Compounds/therapeutic use; Spinal Cord Injuries/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phototherapy / Adrenal Cortex Hormones / Dermatitis, Seborrheic / Enzyme Inhibitors / Keratolytic Agents / Antifungal Agents Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Br J Hosp Med (Lond) Year: 2017 Document type: Article

Fulltext

XML

PubMed Links

Search on Google